Pertuzumab biosimilar (CTTQ) | m-entrepreneurship.com

Product Name :
Pertuzumab biosimilar (CTTQ)

Search keywords :
Pertuzumab

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-2

Target Vo Short Name :
HER2

Moa_Name:
Anti-HER2

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd

Active Company_Name :
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC1 Rabbit mAb Cancer
Alirocumab supplier
TLR2 Antibody: TLR2 Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-TLR2 polyclonal antibody. TLR2 Antibody can be used for: WB, IHC-P, IHC-F expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts